When bound to these receptors, the action of GLP-1 antagonist has the following effects: Stimulates the production of insulin Reduces glucagon production in the liver Signals to the brain a feeling of fullness Slows the rate of gastric emptying This results in: Better regulation of blood sugar levels Reduction of appetite Reduction of food intake Weight loss In other words, patients get full quickly, stay full longer, and rarely have food cravings or hunger
For researchers serious about navigating their GLP-1 options with confidence, SeekPeptides provides the most comprehensive educational resource available, with evidence-based guides on every major GLP-1 medication, dosage calculators , comparison tools, and a community of knowledgeable members who have navigated these exact conversations successfully
Programs that offer subscription-based medication services often cost upwards of $300 per month, and these non-FDA approved compounded GLP-1 medications raise serious concerns due to variability in dosage, potential for harmful additives, and lack of rigorous safety and efficacy testing
Major studies leading to the approval of naltrexone/bupropion reported an average placebo-subtracted weight loss of 3.7% at a dose of 16/360 mg, and 4.8% at a dose of 32/360 mg
22 C during light and 18 C during darkness
The nationwide poll was conducted January 9-13, 2025 using the AmeriSpeak Panel, the probability-based panel of NORC at the University of Chicago